967 related articles for article (PubMed ID: 2601685)
21. Evidence for two cholecystokinin receptors mediating the contraction of the guinea pig isolated ileum longitudinal muscle myenteric plexus.
Dal Forno G; Pietra C; Urciuoli M; van Amsterdam FT; Toson G; Gaviraghi G; Trist D
J Pharmacol Exp Ther; 1992 Jun; 261(3):1056-63. PubMed ID: 1602372
[TBL] [Abstract][Full Text] [Related]
22. The use of topographical constraints in receptor mapping: investigation of the topographical requirements of the tryptophan 30 residue for receptor binding of Asp-Tyr-D-Phe-Gly-Trp-(N-Me)Nle-Asp-Phe-NH2 (SNF 9007), a cholecystokinin (26-33) analogue that binds to both CCK-B and delta-opioid receptors.
Boteju LW; Nikiforovich GV; Haskell-Luevano C; Fang SN; Zalewska T; Stropova D; Yamamura HI; Hruby VJ
J Med Chem; 1996 Sep; 39(20):4120-4. PubMed ID: 8831778
[TBL] [Abstract][Full Text] [Related]
23. Type-A cholecystokinin receptors in CHP212 neuroblastoma cells: evidence for association with G protein and activation of phosphoinositide hydrolysis.
Barrett RW; Steffey ME; Wolfram CA
Mol Pharmacol; 1989 Apr; 35(4):394-400. PubMed ID: 2539554
[TBL] [Abstract][Full Text] [Related]
24. CCK-8, CCK-4 and gastrin-induced contractions in guinea pig ileum: evidence for differential release of acetylcholine and substance P by CCK-A and CCK-B receptors.
Lucaites VL; Mendelsohn LG; Mason NR; Cohen ML
J Pharmacol Exp Ther; 1991 Feb; 256(2):695-703. PubMed ID: 1704435
[TBL] [Abstract][Full Text] [Related]
25. Cholecystokinin receptors: relationships among phosphoinositide breakdown, amylase release and receptor affinity in pancreas.
Lin CW; Bianchi BR; Grant D; Miller T; Danaher EA; Tufano MD; Kopecka H; Nadzan AM
J Pharmacol Exp Ther; 1986 Mar; 236(3):729-34. PubMed ID: 2419543
[TBL] [Abstract][Full Text] [Related]
26. The use of receptor desensitization to analyse CCKA and CCKB/gastrin receptors coupled to contraction in guinea-pig stomach muscle.
Bishop LA; Gerskowitch VP; Hull RA; Shankley NP; Black JW
Br J Pharmacol; 1995 Jan; 114(2):339-48. PubMed ID: 7881733
[TBL] [Abstract][Full Text] [Related]
27. Pancreatic receptors for cholecystokinin: evidence for three receptor classes.
Yu DH; Huang SC; Wank SA; Mantey S; Gardner JD; Jensen RT
Am J Physiol; 1990 Jan; 258(1 Pt 1):G86-95. PubMed ID: 2301586
[TBL] [Abstract][Full Text] [Related]
28. Cholecystokinin type A and type B receptor antagonists produce opposing effects on cholecystokinin-stimulated beta-endorphin secretion from the rat pituitary.
Millington WR; Mueller GP; Lavigne GJ
J Pharmacol Exp Ther; 1992 May; 261(2):454-61. PubMed ID: 1578360
[TBL] [Abstract][Full Text] [Related]
29. Structure-based design of new constrained cyclic agonists of the cholecystokinin CCK-B receptor.
Blommaert AG; Dhôtel H; Ducos B; Durieux C; Goudreau N; Bado A; Garbay C; Roques BP
J Med Chem; 1997 Feb; 40(5):647-58. PubMed ID: 9057851
[TBL] [Abstract][Full Text] [Related]
30. Conformationally constrained CCK8 analogues obtained from a rationally designed peptide library as ligands for cholecystokinin type B receptor.
De Luca S; Saviano M; Della Moglie R; Digilio G; Bracco C; Aloj L; Tarallo L; Pedone C; Morelli G
ChemMedChem; 2006 Sep; 1(9):997-1006. PubMed ID: 16915602
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological properties of lorglumide as a member of a new class of cholecystokinin antagonists.
Makovec F; Bani M; Cereda R; Chisté R; Pacini MA; Revel L; Rovati LA; Rovati LC; Setnikar I
Arzneimittelforschung; 1987 Nov; 37(11):1265-8. PubMed ID: 3440035
[TBL] [Abstract][Full Text] [Related]
32. Cardiovascular effects of cholecystokinin-4 are mediated by the cholecystokinin-B receptor subtype in the conscious guinea pig and dog.
Fossa AA; DePasquale MJ; Morrone J; Zorn SH; Bryce D; Lowe JA; McLean S
J Pharmacol Exp Ther; 1997 Apr; 281(1):180-7. PubMed ID: 9103496
[TBL] [Abstract][Full Text] [Related]
33. CCK antagonists interact with CCK-B receptors on human small cell lung cancer cells.
Staley J; Jensen RT; Moody TW
Peptides; 1990; 11(5):1033-6. PubMed ID: 2178246
[TBL] [Abstract][Full Text] [Related]
34. Characterization of gastrin receptors on guinea pig pancreatic acini.
Yu DH; Noguchi M; Zhou ZC; Villanueva ML; Gardner JD; Jensen RT
Am J Physiol; 1987 Dec; 253(6 Pt 1):G793-801. PubMed ID: 2447788
[TBL] [Abstract][Full Text] [Related]
35. Cholecystokinin antagonists.
Maton PN; Jensen RT; Gardner JD
Horm Metab Res; 1986 Jan; 18(1):2-9. PubMed ID: 2419234
[TBL] [Abstract][Full Text] [Related]
36. Differentiation of central and peripheral cholecystokinin receptors by new glutaramic acid derivatives with cholecystokinin-antagonistic activity.
Makovec F; Bani M; Chisté R; Revel L; Rovati LC; Rovati LA
Arzneimittelforschung; 1986; 36(1):98-102. PubMed ID: 3006713
[TBL] [Abstract][Full Text] [Related]
37. Cholecystokinin and gastrin induce cell contraction in pig ileum by interacting with different receptor subtypes.
Botella A; Delvaux M; Berry P; Frexinos J; Bueno L
Gastroenterology; 1992 Mar; 102(3):779-86. PubMed ID: 1537515
[TBL] [Abstract][Full Text] [Related]
38. Gastrin and CCK activate phospholipase C and stimulate pepsinogen release by interacting with two distinct receptors.
Qian JM; Rowley WH; Jensen RT
Am J Physiol; 1993 Apr; 264(4 Pt 1):G718-27. PubMed ID: 8476056
[TBL] [Abstract][Full Text] [Related]
39. Cholecystokinin receptors on gallbladder muscle and pancreatic acinar cells: a comparative study.
von Schrenck T; Moran TH; Heinz-Erian P; Gardner JD; Jensen RT
Am J Physiol; 1988 Oct; 255(4 Pt 1):G512-21. PubMed ID: 3177648
[TBL] [Abstract][Full Text] [Related]
40. Partial agonism by gastrin for a cholecystokinin receptor mediating pepsinogen secretion.
Tang LH; Miller MD; Goldenring JR; Modlin IM; Hersey SJ
Am J Physiol; 1993 Nov; 265(5 Pt 1):G865-72. PubMed ID: 8238515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
